Back to CHRS Stock Lookup

Coherus BioSciences (CHRS) – Company Press Releases

Feb 5, 2016 09:30 AM Coherus BioSciences to Present at Bloomberg Intelligence Healthcare Event on February 12th
Feb 1, 2016 04:15 PM Coherus Announces the Appointment of Jim Daly, Executive Chairman, Commercial Advisory Committee
Feb 1, 2016 04:05 PM Coherus Announces CHS-1701 (Neulasta® Biosimilar) Met Both Primary Endpoints in Registration-Enabling Immunogenicity Study
Jan 11, 2016 06:45 AM Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoint in Phase 3 Rheumatoid Arthritis Clinical Study (RaPsODY)
Jan 4, 2016 09:30 AM Coherus BioSciences to Present at J.P. Morgan Healthcare Conference on January 11
Dec 21, 2015 09:30 AM Coherus BioSciences Signs Strategic Manufacturing Agreement With KBI Biopharma for Commercial Supply of CHS-1701
Dec 8, 2015 04:00 PM Coherus BioSciences Reports Update to CHS-1701 Program
Nov 10, 2015 09:30 AM Coherus BioSciences to Present at Jefferies Autumn 2015 Global Healthcare Conference on November 18
Nov 9, 2015 04:05 PM Coherus BioSciences Reports Third Quarter 2015 Financial and Operating Results and Corporate Events
Nov 9, 2015 04:01 PM Coherus and Baxalta Announce CHS-0214 (Investigational Etanercept Biosimilar) Met Primary Efficacy Endpoints in Phase 3 Psoriasis Clinical Study (RaPsODY)
Oct 28, 2015 09:30 AM Coherus BioSciences to Present at Credit Suisse Healthcare Conference on November 10
Oct 27, 2015 09:30 AM Coherus BioSciences to Present at Bloomberg Biosimilars Conference on November 2
Oct 26, 2015 04:30 PM Coherus BioSciences to Report Third Quarter 2015 Financial Results on November 9
Oct 1, 2015 04:08 PM Coherus Announces Topline Results of CHS-1701 Pharmacokinetic and Pharmacodynamic Biosimilarity Study
Oct 1, 2015 04:08 PM Coherus Announces Topline Results of CHS-1701 Pharmacokinetic and Pharmacodynamic Biosimilarity Study
Sep 9, 2015 09:00 AM Coherus Appoints Juliana M. Reed, Vice President, Government Affairs
Sep 4, 2015 09:00 AM Coherus BioSciences to Present at Morgan Stanley Global Healthcare Conference on September 17
Sep 4, 2015 09:00 AM Coherus BioSciences to Present at Morgan Stanley Global Healthcare Conference on September 17
Sep 3, 2015 04:01 PM Coherus Provides Updates on Clinical Studies
Sep 3, 2015 04:01 PM Coherus Provides Updates on Clinical Studies
Aug 10, 2015 04:02 PM Coherus BioSciences Reports Second Quarter 2015 Financial and Operating Results
Aug 10, 2015 04:02 PM Coherus BioSciences Reports Second Quarter 2015 Financial and Operating Results
Jul 28, 2015 09:00 AM Coherus BioSciences to Report Second Quarter 2015 Financial Results on August 10
May 27, 2015 09:00 AM Coherus BioSciences to Present at Jefferies Healthcare Conference on June 3
May 11, 2015 04:05 PM Coherus BioSciences Reports First Quarter 2015 Financial and Operating Results
May 4, 2015 09:00 AM Coherus BioSciences to Report First Quarter 2015 Financial Results on May 11
May 4, 2015 09:00 AM Coherus BioSciences to Report First Quarter 2015 Financial Results on May 11
Apr 30, 2015 09:00 AM Coherus BioSciences to Present at Deutsche Bank Health Care Conference on May 7
Apr 15, 2015 08:00 AM Coherus BioSciences and Baxter Announce Amendment to Etanercept Biosimilar Collaboration Agreement
Mar 31, 2015 09:50 PM Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock
Mar 31, 2015 09:50 PM Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock
Mar 30, 2015 04:01 PM Coherus Announces Proposed Public Offering of Common Stock
Mar 30, 2015 04:01 PM Coherus Announces Proposed Public Offering of Common Stock
Mar 23, 2015 04:00 PM Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating Results
Mar 23, 2015 04:00 PM Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating Results
Mar 23, 2015 04:00 PM Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating Results
Mar 17, 2015 09:00 AM Coherus Finalizes CHS-1701 BLA Enabling Clinical Program and Initiates Pivotal Pharmacokinetic and Pharmacodynamic Study
Mar 17, 2015 09:00 AM Coherus Finalizes CHS-1701 BLA Enabling Clinical Program and Initiates Pivotal Pharmacokinetic and Pharmacodynamic Study
Mar 16, 2015 09:00 AM Coherus BioSciences to Report Fourth Quarter and Year End 2014 Financial Results on March 23
Feb 23, 2015 06:00 PM Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2
Dec 8, 2014 09:00 AM Coherus BioSciences to Present at the J.P. Morgan Healthcare Conference on January 12
Dec 4, 2014 04:05 PM Coherus BioSciences to Host Earnings Conference Call on December 15
Nov 12, 2014 06:59 PM Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares
Nov 6, 2014 11:52 AM Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock

Back to CHRS Stock Lookup